STOCK TITAN

DILLARD'S, INC. (DDS) SEC Filings

DDS NYSE

Welcome to our dedicated page for DILLARD'S SEC filings (Ticker: DDS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Dillard’s, Inc. files SEC reports that document its retail operations, capital structure, governance and material corporate events. Recent 8-K disclosures cover operating results and financial condition, including sales, gross margin, expenses, inventory and net income measures for the company’s department-store and related businesses.

The filings also identify Class A Common Stock trading on the New York Stock Exchange under DDS and record corporate governance actions, shareholder-rights modifications, the company’s Texas corporate status, amendments to charter-related instruments and material definitive agreements. Proxy-solicitation and shareholder-vote disclosures appear where governance or transaction matters require formal investor communications.

Rhea-AI Summary

DILLARD'S, INC. (DDS) reports that officer Dean L. Worley, its Vice President, General Counsel and Secretary, made a bona fide gift of 100 shares of Common Class A stock on September 4, 2026. After this gift, he holds 6,416 Common Class A shares directly and 3,565 shares through a retirement plan. No transactions are reported under a Rule 10b5-1 trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DILLARD'S, INC. (DDS) reports that Senior Vice President Phillip R. Watts made a bona fide gift of 400 shares of Common Class A on September 4, 2026. After the gift, he holds 8,746 Common Class A shares directly and 10,378 Common Class A shares through a retirement plan. No Rule 10b5-1 trading plan is reported for these transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DILLARD’S, INC. (DDS) reported roughly flat quarterly net sales of $1.51 billion for the three months ended August 1, 2026, but net income rose to $97.7 million or $6.25 per share from $72.8 million or $4.66 a year earlier.

Retail sales grew about 1% and retail gross margin increased to 40.9% from 38.1%, aided by $37.2 million of International Emergency Economic Powers Act tariff refunds, which added 260 basis points to margin. For the first six months, net income was $348.2 million or $22.30 per share versus $236.7 million or $15.08, helped by a $104.1 million credit card interchange fee litigation settlement.

Operating cash flow for the first half was $326.8 million, and Dillard’s ended the quarter with $763.1 million in cash plus $497.7 million in short-term investments and $425.7 million of total debt. The company paid down $96 million of notes, had no borrowings on its $800 million revolver, and still has $165.2 million remaining under its stock repurchase authorization, though no shares were repurchased in the period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

DILLARD'S, INC. (DDS) reported that Senior Vice President and director Denise Dillard Mahaffy acquired 9 shares of Class A common stock on 2026-08-24 as a grant, award, or other acquisition at $638.19 per share, bringing her directly held Class A position to 166,653 shares.

She also directly holds 273,724 shares of Class B common stock, which are convertible into Class A on a one-for-one basis, and indirectly holds 7,300 Class A shares through a trust for which she serves as trustee. Beneficial ownership was adjusted to reflect that 60 Class A shares were transferred from her retirement plan to a brokerage account on 2026-08-04, leaving 0 Class A shares in the retirement-plan account.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DILLARD'S, INC. (symbol: DDS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DILLARD'S, INC. (DDS) reported that a company officer received an equity award. On 2026-08-24, the reporting person, who serves as VP/General Counsel & Secretary, acquired 8 shares of Common Class A as a grant, award, or other acquisition at a reported price of $638.19 per share, bringing this direct holding to 6,516 shares. A separate line reports 3,565 shares of Common Class A held in a retirement plan as a direct holding, with no specific transaction reported for that entry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

DILLARD'S, INC. (DDS) reported that Senior Vice President Phillip R. Watts acquired 9 shares of Common Class A stock on 2026-08-24 through a grant or award at a reported price of $638.19 per share. Following this award, he directly holds 9,146 Common Class A shares. A separate line shows 10,378 Common Class A shares held in a retirement plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DILLARD'S, INC. (DDS) reported that officer James D. Stockman, Vice President, received a grant/award of 11 shares of Common Class A stock on 2026-08-24 at a reported price of $638.19 per share. Following this acquisition, his directly held Common Class A position is 35,434 shares, plus 21,138 shares held in a retirement plan account.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DILLARD'S, INC. (DDS) reported that a corporate vice president of stores received a grant or award acquisition of 7 shares of Common Class A stock on 2026-08-24 at a reported price of $638.19 per share. Following this award, the reporting person holds 3,357 Common Class A shares directly, plus 8,510 shares held in a retirement plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

DILLARD'S, INC. (symbol: DDS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many DILLARD'S (DDS) SEC filings are available on StockTitan?

StockTitan tracks 254 SEC filings for DILLARD'S (DDS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for DILLARD'S (DDS)?

The most recent SEC filing for DILLARD'S (DDS) was filed on September 4, 2026.